Biologically Inspired Engineering, synbio, synthetic biology, crispr
Staff 
In June, a U.S. Army laboratory, the Walter Reed Army Institute of Research (WRAIR), a subordinate command of the Army Futures Command’s Medical Research and Development Command (USAMRDC), announced the selection of a lead COVID-19 vaccine candidate as well as two backup vaccine candidates that will advance to the next stage of research. “USAMRDC is … Read more
Protein synthesizers speed up the production of enzymes, therapeutics and lab reagents. Toronto-based Liberumbio’s product use proprietary molecular and hardware technology, enabling biological manufacturer to bring speed, scalability and to reduce cost to protein synthesis. The market size of recombinant proteins today is $119 billion. But it’s expected to reach $400 billion just by 2025. … Read more
IndieBio announced its new batches of startups in June. The life sciences startup incubator allocates each team $250,000 in seed funding plus lab and co-working space and dedicated mentorship. Afterwards, each company becomes part of a network of IndieBio alumni, investors, and biotech entrepreneurs. This is New York’s first batch, and San Francisco’s tenth. Though … Read more
The Pershing Square Foundation recently announced that it has awarded $3 million to nineteen recipients at ten academic research institutions in furtherance of conducting research related to the SARS-CoV-2 virus. As scientists across various disciplines around the world have risen to the challenge of combating SARS-CoV-2, The Pershing Square Foundation (the “Foundation”) worked with its … Read more
In 2017, the National Science Foundation (NSF) unveiled a set of “Big Ideas,” 10 bold, long-term research and process ideas that identify areas for future investment at the frontiers of science and engineering. Synthetic biology, or “Understanding the Rules of Life,” is one of the NSF’s big ideas. The ability to design and manufacture synthetic … Read more
Eligo Bioscience, is a Paris-based next-generation microbiome precision medicine company Eligo Bioscience is pioneering the development of phage-derived DNA delivery vectors for microbial species involved in a number of diseases areas, including infectious diseases, inflammatory diseases and auto-immune diseases. Eligo Bioscience’s EligobioticsTM Plaform EligobioticsTM platform enables the production of DNA delivery vectors derived from phage-like … Read more
The McKinsey Global Institute has published a tome, “The Bio Revolution” that attempts to quantify the risks and opportunities for synthetic biology. Here is the document’s glossary: Allele. Any of the alternative forms of a gene that may occur at a given locus.Bioinformatics. A hybrid science between computer science, biology, and statistics that involves the … Read more
Global food security is a big concept for a small company. To achieve its lofty goals, Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yields. The company has an extensive track record of innovation based around optimizing the flow of carbon in living systems, and it is leveraging … Read more
The McKinsey Global Institute (MGI) has outlined in “The Bio Revolution” the current state of innovation in agriculture, aquaculture, and food. According to MGI, humans have been growing crops and raising animals for thousands of years using a evolving set of tools and techniques. Since the dawn of agriculture, humans have used tools like selective … Read more
Invitae (NYSE: NVTA), a leading genetics and synthetic biology company, and ArcherDX, a leading genomics analysis company innovating in precision oncology, today announced the companies have entered into an agreement to combine. The combined company aims to advance care for cancer patients by accelerating adoption of genetics . Integrating germline testing, tumor profiling and liquid biopsy … Read more